PERIACTIN Trademark

Trademark Overview

On Friday, October 14, 2016, a trademark application was filed for PERIACTIN with the United States Patent and Trademark Office. The USPTO has given the PERIACTIN trademark a serial number of 87204036. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, June 8, 2020. This trademark is owned by Gemini Laboratories, LLC. The PERIACTIN trademark is filed in the Pharmaceutical Products category with the following description:

Medicinal compound for use as an antihistaminic, anti-cholinergic, antipruritic and serotonin antagonist
periactin

General Information

Serial Number87204036
Word MarkPERIACTIN
Filing DateFriday, October 14, 2016
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, June 8, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 28, 2017

Trademark Statements

Goods and ServicesMedicinal compound for use as an antihistaminic, anti-cholinergic, antipruritic and serotonin antagonist

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, October 19, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGemini Laboratories, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressBridgewater, NJ 08807
Party NameGemini Laboratories, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressBridgewater, NJ 08807

Trademark Events

Event DateEvent Description
Monday, June 8, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, June 8, 2020ABANDONMENT - NO USE STATEMENT FILED
Saturday, October 26, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 25, 2019EXTENSION 5 GRANTED
Tuesday, October 22, 2019EXTENSION 5 FILED
Thursday, October 24, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, October 22, 2019TEAS EXTENSION RECEIVED
Saturday, April 20, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 18, 2019EXTENSION 4 GRANTED
Thursday, April 18, 2019EXTENSION 4 FILED
Thursday, April 18, 2019TEAS EXTENSION RECEIVED
Friday, October 12, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 10, 2018EXTENSION 3 GRANTED
Wednesday, October 10, 2018EXTENSION 3 FILED
Wednesday, October 10, 2018TEAS EXTENSION RECEIVED
Wednesday, April 25, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 23, 2018EXTENSION 2 GRANTED
Monday, April 23, 2018EXTENSION 2 FILED
Monday, April 23, 2018TEAS EXTENSION RECEIVED
Friday, October 27, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 25, 2017EXTENSION 1 GRANTED
Wednesday, October 25, 2017EXTENSION 1 FILED
Wednesday, October 25, 2017TEAS EXTENSION RECEIVED
Tuesday, April 25, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 28, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 28, 2017PUBLISHED FOR OPPOSITION
Wednesday, February 8, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, January 25, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, January 24, 2017ASSIGNED TO EXAMINER
Wednesday, October 19, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, October 18, 2016NEW APPLICATION ENTERED IN TRAM

Related Keywords

periactin antipruritic serotonin antagonist cholinergic anti compound antihistaminic medicinal